As of April 19, 2025, TScan Therapeutics (TCRX) has a market cap of $81.490 million USD. According to our data, TScan Therapeutics is ranked No.7730 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $81.49 M |
-48.68%
|
Dec 31, 2024 | $0.16 B |
-47.86%
|
Dec 29, 2023 | $0.30 B |
276.13%
|
Dec 30, 2022 | $80.95 M |
-65.56%
|
Dec 31, 2021 | $0.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$61.27 M |
0.051 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$36.15 M |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() Legend Biotech
LEGN
|
$6.02 B |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
Market Cap | = | TCRX Stock Price | * | TCRX Shares Outstanding |
= | $1.44 | * | 52.31 M | |
= | $81.49 M |